“Your findings have great relevance for our businesses. We will move faster in China than originally planned.” Hans Keil, E-Business Manager, PerkinElmer.

We understand your business The Life Science practice covers a wide range of products and services in the pharmaceuticals, biotechnology and medical sectors. These industries are currently facing dramatic changes in Asia which will have strategic implications for every player aiming to secure a viable position in the global marketplace. The emergence of a fast-growing life science market in Asia has been fueled by the recent rapid development of Asian economies, increases in disposable income and the presence of vast populations across the continent. The long term prospects remain positive as the market is still relatively untapped by companies working to Western standards.

At the same time, Asian countries have taken steps to develop manufacturing and research facilities, with significant differences across the region in terms of involvement, priorities and means.

Many governments, for example in India and Taiwan, have taken active steps to develop research and/or manufacturing facilities, making full use of a highly trained workforce or low manufacturing costs.

Life Science companies aiming to establish and develop their presence in Asia will need to strike a fine balance between long term strategic choices and fast changing markets while understanding and competing effectively with intense local rivalry.

Gain from our experience
Most sectors – whether healthcare services, equipment, diagnostics, pharmaceuticals, vaccines or biotechnology – are undergoing important changes in the region.

We help our clients, which include Bayer, Johnson & Johnson and Serono, make the most of these.

Contact us now to find out how we can help you succeed in the Asia-Pacific region. Please use our online form or phone the practice head, Morris Lee, on +65 6423 1681.